pd 98059 has been researched along with Carcinoma, Renal Cell in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, H | 1 |
| Deng, L | 1 |
| Kanda, S | 1 |
| Kanetake, H | 1 |
| Miyata, Y | 1 |
2 other studies available for pd 98059 and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Sphingosine kinase-1 activation causes acquired resistance against Sunitinib in renal cell carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Drug Resistance, Neop | 2014 |
Long-term exposure of human renal carcinoma cells to PD98059 induces epithelial-mesenchymal transition-like phenotype and enhanced motility.
Topics: Amides; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Enzyme Activation; Epithelium; Extra | 2008 |